Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16699374 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant
Conditions: AML;   CML;   MDS
Interventions: Drug: CYT107 - Recombinant glycosylated human interleukin 7.;   Drug: rhIL-7 (CYT107)
2 Completed Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: MART-1 antigen;   Biological: gp100 antigen;   Biological: incomplete Freund's adjuvant;   Biological: recombinant interleukin-7
3 Active, not recruiting Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
Condition: Metastatic Breast Cancer
Interventions: Drug: placebo;   Drug: interleukin 7

Indicates status has not been verified in more than two years